Preclinical evaluation of an 18 F-labeled N ε -acryloyllysine piperazide for covalent targeting of transglutaminase 2.
Robert WodtkeMarkus LaubeSandra HauserSebastian MeisterFriedrich-Alexander LudwigSteffen FischerKlaus KopkaJens PietzschReik LöserPublished in: EJNMMI radiopharmacy and chemistry (2024)
F]7b requires appropriate structural modifications to overcome these limitations.